Irene van der Horst-Bruinsma Selected Research

Irene van der Horst-Bruinsma Research Topics

8	Axial Spondyloarthritis 04/2024 - 06/2017
7	Ankylosing Spondylitis 04/2024 - 07/2003
6	Arthritis (Polyarthritis) 02/2023 - 10/2002
3	Pain (Aches) 01/2024 - 07/2003
3	Psoriatic Arthritis 01/2024 - 01/2022
2	Fatigue 01/2024 - 01/2023
2	Rheumatoid Arthritis 10/2022 - 10/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2010 - 07/2003
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023
1	COVID-19 07/2023
1	Post-Acute COVID-19 Syndrome 07/2023
1	Rheumatic Diseases (Rheumatism) 02/2023
1	Non-Radiographic Axial Spondyloarthritis 01/2023
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	Overweight 01/2020
1	Obesity 01/2020
1	Anterior Uveitis 01/2020
1	Sacroiliitis 06/2017
1	Inflammation (Inflammations) 06/2017
1	Bone Resorption 08/2004
1	Spondylarthropathies 07/2003
1	Synovitis 07/2003
1	Enthesopathy 07/2003

5	Tumor Necrosis Factor InhibitorsIBA 05/2024 - 01/2020
4	C-Reactive ProteinIBA 04/2024 - 07/2003
4	secukinumabIBA 01/2024 - 01/2020
4	Antirheumatic Agents (DMARD)IBA 11/2022 - 06/2017
3	AntibodiesIBA 11/2010 - 10/2002
2	ametantrone (HAQ)IBA 01/2024 - 01/2023
2	Certolizumab Pegol FDA Link 10/2022 - 01/2020
2	cyclic citrullinated peptideIBA 08/2003 - 10/2002
2	Anti-Citrullinated Protein AntibodiesIBA 08/2003 - 10/2002
1	Prostaglandins AIBA 01/2024
1	AntigensIBA 07/2023
1	tocilizumab (atlizumab)FDA Link 10/2022
1	Abatacept (Orencia)FDA Link 10/2022
1	Methotrexate (Mexate)FDA LinkGeneric 10/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	golimumab FDA Link 01/2021
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	LeptinIBA 01/2020
1	AdipokinesIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 06/2017
1	GlucocorticoidsIBA 06/2017
1	Adalimumab (Humira)FDA Link 04/2012
1	OsteocalcinIBA 08/2004
1	Biomarkers (Surrogate Marker)IBA 08/2004
1	collagen type I trimeric cross-linked peptideIBA 08/2004
1	Mesalamine (Mesalazine)FDA LinkGeneric 07/2003
1	Immunoglobulin A (IgA)IBA 10/2002
1	Rheumatoid FactorIBA 10/2002
1	Immunoglobulin M (IgM)IBA 10/2002

4	Therapeutics 11/2023 - 04/2012